• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症筛查:科学与直觉的冲突。

Cancer screening: the clash of science and intuition.

作者信息

Kramer Barnett S, Croswell Jennifer Miller

机构信息

Office of Disease Prevention, Office of the Director, National Institutes of Health, Bethesda, Maryland 20892, USA.

出版信息

Annu Rev Med. 2009;60:125-37. doi: 10.1146/annurev.med.60.101107.134802.

DOI:10.1146/annurev.med.60.101107.134802
PMID:18803476
Abstract

The concept of early detection of cancer holds great promise and intuitive appeal. However, powerful biases can mislead clinicians when evaluating the efficacy of screening tests by clinical observation alone. Selection bias, lead-time bias, length-biased sampling, and overdiagnosis are counterintuitive concepts with critical implications for early-detection efforts. This article explains these biases and other common confounders in cancer screening. The most direct and reliable way to avoid being led astray by intuitions is through the use of randomized controlled trials.

摘要

癌症早期检测的概念前景广阔且颇具直观吸引力。然而,在仅通过临床观察评估筛查测试的疗效时,强大的偏差可能会误导临床医生。选择偏差、领先时间偏差、长度偏倚抽样和过度诊断是一些违反直觉的概念,对早期检测工作有着至关重要的影响。本文解释了这些偏差以及癌症筛查中其他常见的混杂因素。避免被直觉误导的最直接、最可靠的方法是采用随机对照试验。

相似文献

1
Cancer screening: the clash of science and intuition.癌症筛查:科学与直觉的冲突。
Annu Rev Med. 2009;60:125-37. doi: 10.1146/annurev.med.60.101107.134802.
2
The science of early detection.
Urol Oncol. 2004 Jul-Aug;22(4):344-7. doi: 10.1016/j.urolonc.2003.04.001.
3
Screening for cancer: evaluating the evidence.癌症筛查:评估证据
Am Fam Physician. 2001 Feb 1;63(3):513-22.
4
[Problems in using survival data of cancer patients as a method of gauging the effectiveness of cancer control efforts].
Gan No Rinsho. 1988 Oct;34(12):1637-41.
5
Bias in breast cancer research in the screening era.筛查时代乳腺癌研究中的偏倚
Breast. 2013 Dec;22(6):1041-5. doi: 10.1016/j.breast.2013.07.046. Epub 2013 Aug 26.
6
Cancer screenings, diagnostic technology evolution, and cancer control.癌症筛查、诊断技术的发展与癌症控制。
Methods Mol Biol. 2009;471:107-36. doi: 10.1007/978-1-59745-416-2_6.
7
Assessing the efficacy of cancer screening.评估癌症筛查的效果。
Public Health Res Pract. 2017 Jul 26;27(3):2731727. doi: 10.17061/phrp2731727.
8
Principles of cancer screening: lessons from history and study design issues.癌症筛查原则:从历史和研究设计问题中吸取的教训。
Semin Oncol. 2010 Jun;37(3):202-15. doi: 10.1053/j.seminoncol.2010.05.006.
9
Efforts in fighting against cancer in Croatia have to be focused on the primary health care.克罗地亚抗击癌症的工作必须聚焦于初级卫生保健。
Coll Antropol. 2008 Sep;32(3):709-24.
10
Effect of length biased sampling of unobserved sojourn times on the survival distribution when disease is screen detected.疾病通过筛查检测出时,未观察到的停留时间的长度偏倚抽样对生存分布的影响。
Stat Med. 2009 Jul 20;28(16):2116-46. doi: 10.1002/sim.3601.

引用本文的文献

1
Treating Cardiovascular Disorders with Personalized Medicine.用个性化医疗治疗心血管疾病。
Cardiovasc Hematol Disord Drug Targets. 2025;25(2):98-118. doi: 10.2174/011871529X361429250215190129.
2
Benefits and harms of screening for hepatocellular carcinoma in high-risk populations: systematic review and meta-analysis.高危人群肝细胞癌筛查的利弊:系统评价与荟萃分析
J Natl Cancer Cent. 2023 Feb 24;3(3):175-185. doi: 10.1016/j.jncc.2023.02.001. eCollection 2023 Sep.
3
MRI Using Gadoxetic Acid in the Work-Up of Liver Nodules Not Conclusively Benign in Budd-Chiari Syndrome: A Prospective Long-Term Follow-Up.
使用钆塞酸二钠磁共振成像对布加综合征中不能明确为良性的肝脏结节进行检查:一项前瞻性长期随访研究
Liver Cancer. 2023 Aug 18;13(2):203-214. doi: 10.1159/000533598. eCollection 2024 Apr.
4
Pharmacotherapy for Disease Modification in Early Parkinson's Disease: How Early Should We Be?早期帕金森病的疾病修饰治疗:我们应该多早开始?
J Parkinsons Dis. 2024;14(s2):S407-S421. doi: 10.3233/JPD-230354.
5
Overdiagnosis Due to Screening Mammography for Breast Cancer among Women Aged 40 Years and Over: A Systematic Review and Meta-Analysis.40岁及以上女性乳腺癌筛查钼靶摄影导致的过度诊断:一项系统评价和荟萃分析
J Pers Med. 2023 Mar 14;13(3):523. doi: 10.3390/jpm13030523.
6
Comparative effectiveness of different hepatocellular carcinoma screening intervals or modalities: a systematic review and meta-analysis.不同肝癌筛查间隔或方式的比较效果:系统评价和荟萃分析。
Chin Med J (Engl). 2023 Jun 5;136(11):1322-1330. doi: 10.1097/CM9.0000000000002341.
7
Cancer overdiagnosis: a challenge in the era of screening.癌症过度诊断:筛查时代的一项挑战。
J Natl Cancer Cent. 2022 Dec;2(4):235-242. doi: 10.1016/j.jncc.2022.08.005. Epub 2022 Aug 21.
8
A natural history and copula-based joint model for regional and distant breast cancer metastasis.基于自然史和连接函数的局部和远处乳腺癌转移联合模型。
Stat Methods Med Res. 2022 Dec;31(12):2415-2430. doi: 10.1177/09622802221122410. Epub 2022 Sep 18.
9
Stage Migration and Lung Cancer Incidence After Initiation of Low-Dose Computed Tomography Screening.启动低剂量 CT 筛查后肺癌发病率的阶段迁移。
J Thorac Oncol. 2022 Dec;17(12):1355-1364. doi: 10.1016/j.jtho.2022.08.011. Epub 2022 Sep 7.
10
Assessing lead time bias due to mammography screening on estimates of loss in life expectancy.评估因乳腺 X 光筛查而导致的预期寿命损失的领先时间偏倚。
Breast Cancer Res. 2022 Feb 23;24(1):15. doi: 10.1186/s13058-022-01505-3.